Growing prevalence of various diseases in the country is expected to drive the growth of UAE Pharmaceutical Market, in the forecast period, 2024-2028.
According to TechSci report on, “UAE Pharmaceutical Market – By Region, Competition Forecast & Opportunities, 2028” UAE pharmaceutical market is anticipated to grow with an impressive rate in the forecast period, 2024-2028 on the account of involvement of government through multiple schemes and favorable plans to sustain pharmaceutical industry. Abu Dhabi Vision 2030, Dubai Industrial Strategy 2030 are two major initiatives from the UAE government to advance the pharmaceutical industry through increasing investment and promoting UAE productions of pharmaceuticals. The UAE government is also imposing special attention toward local pharmaceutical companies to aid them in increasing their production capacities. Also, the government invites multiple international market players to establish their local manufacturing units in the country to promote its pharmaceutical industry. Moreover, increasing instances of infectious diseases, chronic diseases, and lifestyle diseases are also influencing the growth of the UAE pharmaceutical market in the next five years. Patients suffering from chronic diseases are often prescribed prolonged usage of drugs to maintain their health conditions, thus supporting the market growth. Increasing geriatric population, higher demands for over the counter drugs, and rising concerns among the population toward health thus inclination toward vitamin and supplements further substantiate the growth of the UAE pharmaceutical market in the forecast years through 2028.
However, lack of resources may hinder the growth of the market in upcoming years. Besides, the stringent rules and regulations associated with the pharmaceuticals may slow down the growth of UAE pharmaceutical market in the forthcoming years.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on “UAE Pharmaceutical Market“
The UAE pharmaceutical market is segmented by drug type, product type, application, distribution channel, company, and region.
Based on drug type, the market is differentiated between generic drugs and branded drugs. Branded drugs are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the grounds of higher disposable income among the population of the country. Also, increasing penetration into the market by the global giants with their patent products are anticipated to drive the future growth of the UAE pharmaceutical market in the next five years.
Based on product type, market is divided between prescription drugs and over the counter drugs. Over the counter drugs are anticipated to hold the largest revenue shares of the market due to accessibility without any prescription. Increasing trend of self-medication and growing instances of lifestyle diseases are also aiding to the market growth.
Based on application, market is fragmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, and others. Oncology is anticipated to hold the largest revenue shares due to increasing instances of cancer and surfacing of new cases every year. Increasing instances of cardiovascular diseases and growing number of heart failures, open heart surgeries and demand for recovery drugs are expected to support the growth of the cardiovascular segment.
Major companies operating in the UAE pharmaceutical market includes:
- Julphar Gulf Pharmaceutical Industries
- Bayer Consumer Health
- Lifepharma FZE
- Niner Pharmaceuticals LLC
- GlaxoSmithKline & Neopharma
- Pfizer UAE
- Johnson & Johnson Middle East FZ-LLC
Customers can also request for 10% free customization on this report.
“Dubai region is anticipated to lead the regional analysis of the market due to highest number of market players present in the region. This is ascribed to the growing government initiatives and higher investment in the healthcare and pharmaceutical industry. Rising research and development activities in the region as well as the rising demand of dietary supplements are expected to augment the growth of the market through 2028,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“UAE Pharmaceutical Market By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over The Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2028” has evaluated the future growth potential of UAE pharmaceutical market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE pharmaceutical market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com
0
